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FRIP, a Hematopoietic Cell-Specific
rasGAP-Interacting Protein
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IL-4 to the IL-4R (Hou et al., 1994; Ryan et al., 1996). A
second signaling pathway important in IL-4-stimulated
cellular proliferation involves the signaling molecules
IRS-1 and IRS-2, which are highly phosphorylated in
response to IL-4 stimulation of nonhematopoietic and
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National Institutes of Health hematopoietic cells, respectively (Wang et al., 1993a,
Bethesda, Maryland 20892 1993b; Sun et al., 1995). The activation of cellular prolif-
eration has been proposed to occur through the interac-
tion of phosphorylated IRS-1 with additional SH2 do-
main signaling molecules, such as the p85 subunit ofSummary
phosphatidyl-inositol-39 kinase (PI-3-K) and growth fac-
tor receptor-bound protein-2 (Grb2) (Myers et al., 1994).The human IL-4 receptor contains a sequence (the I4R
motif) centered on Y497 that, when phosphorylated, IRS-1 was first identified as a major substrate of the
interacts with phosphotyrosine-binding (PTB) domain insulin and IGF-1 receptors (White and Kahn, 1994) and
proteins. Here, we describe a PTB domain protein, appears important in stimulation of proliferation to these
FRIP, that is phosphorylated in response to cytokine hormones.
stimulation. FRIP is related to the rasGAP-associated A domain containing a conserved Y residue (Y497 of
protein p62dok and is bound by the N-terminal SH2 do- the human IL-4Ra) has been demonstrated to be re-
main of rasGAP. The frip gene maps to the hairless (hr) quired for the activation of IRS-1 and IRS-2 phosphoryla-
locus on mouse chromosome 14. hr/hr mice exhibit tion and is important in the proliferative response of
lymphadenopathy, and their lymph node T cells prolif- hematopoietic cells to IL-4. This Y residue lies within
erate more vigorously to anti-CD3 with IL-4 or IL-2 a sequence (491PLXXXXNPXYXSXS 504) that is highly
stimulation than 1/hr T cells. FRIP expression is sig- conserved between the insulin, IGF-1, and IL-4 recep-
nificantly reduced in T cells from hr/hr mice. FRIP tors (Keegan et al., 1994) (Figure 1A). Thus, this se-
may negatively regulate proliferation by acting as an quence has been termed the insulin/IL-4 receptor (I4R)
adapter molecule between rasGAP and receptor com- motif. Mutation of the central Y of the I4R motif to F
plexes. results in insulin or IL-4 receptors that fail to activate
the phosphorylation of IRS-1 or IRS-2, suggesting that
these molecules interact with the I4R motif only when
Introduction the central Y residue is phosphorylated (Keegan et al.,
1994; Wang et al., 1996). The phosphorylated core se-
Interleukin-4 (IL-4) elicits a broad range of responses in quence of the I4R motif (N-X-X-pY) is a consensus bind-
hematopoietic cells. It has been shown to stimulate the ing sequence for signaling molecules containing a PTB
proliferation of activated B, T, and mast cells (Lee et domain (Trub et al., 1995). Indeed, interaction of IRS-1
al., 1986), to activate the expression of specific genes
with the phosphorylated I4R motif of the insulin receptor
including major histocompatibility (MHC) class II mole-
and with a phosphopeptide of the IL-4R I4R motif has
cules (Noelle et al., 1984), CD23, and germ-line tran-
been demonstrated to occur through a PTB domain in
scripts of the e and g1 Ig constant regions in B cells
the N terminus of the IRS-1 protein (O'Neill et al., 1994;(Conrad et al., 1987; Coffman et al., 1993), and to direct
Eck et al., 1996; Zhou et al., 1996).the differentiation of naive T cells to the Th2 phenotype
Utilizing the yeast two-hybrid system, we attempted(Seder and Paul, 1994). The IL-4 receptor (IL-4R) com-
to identify additional molecules that interact with theplex consists of the primary IL-4 binding chain (IL-4Ra)
phosphorylated I4R motif of the IL-4Ra and that mayand the common gamma chain (gc), which is shared by
be involved in the intracellular pathways regulating IL-4-the receptors for IL-2, IL-7, IL-9, and IL-15 (Leonard et
stimulated proliferation and survival. Here, we describeal., 1995). Recent studies have indicated that different
two additional molecules that interact with the phos-intracellular signaling pathways are activated in re-
phorylated I4R motif of the IL-4R. The first, SHC, hassponse to IL-4R engagement that direct the multiple
been implicated by numerous studies to lead to activa-physiological responses elicited by IL-4. In particular,
tion of the ras/MAP kinase signaling pathway, which candistinct IL-4R signaling pathways have been implicated
contribute to cellular proliferation (Pelicci et al., 1992;in the activation of gene expression and the stimulation
Rozakis-Adcock et al., 1992). The second molecule,of proliferative responses (Wang et al., 1993a; Keegan
termed FRIP, represents a novel member of the growinget al., 1994; Ryan et al., 1996).
family of PTB domain signaling molecules and is highlyA critical event in the activation of IL-4 responsive
genes involves the phosphorylation and nuclear translo- related to the recently identified protein p62dok, which is
cation of the signal transducer and activator of transcrip- associated with ras GTPase activating protein (rasGAP)
tion Stat6, which is specifically activated by binding of in Abl transformed cells (Carpino et al., 1997; Yamanashi
and Baltimore, 1997). We present evidence suggesting
FRIP modulates the cellular proliferation induced by IL-4*To whom correspondence should be addressed (e-mail: wepaul@
helix.nih.gov). as well as the cytokines IL-2 and IL-3.
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Figure 1. Baits Used in the Yeast Two-Hybrid
System to Screen for Proteins That Interact
with the Phosphorylated I4R Motif of the IL-4
Receptor
(A) The I4R motif is conserved between
receptors using the IRS-1/IRS-2 signaling
pathway.
(B) The I4R motif of the IL-4R was fused to
the kinase domain of the insulin receptor
yielding a bait molecule, WT 4R/IRb, capable
of autophosphorylating the I4R motif. The
control bait, Y497F 4R/IRb, is one in which
the central Y of the I4R motif was mutated
to F.
(C) Interaction of the WT 4R/IRb bait with
IRS-1 in the yeast two-hybrid system (WT).
Mutation of the central Y of the I4R motif
blocked the interaction of IRS-1 with the 4R/
IRb bait (Y497F). b-galactosidase activity was
determined as described (O'Neill et al., 1994).
(D) Clones obtained in a yeast two-hybrid
screen of a thymus cDNA library interacted
with the IL-4R/insulin R composite bait con-
taining a phosphorylated (WT) but not an un-
phosphorylated (Y497F) I4R motif.
Results Rozakis-Adcock et al., 1992; Salcini et al., 1994). A sec-
ond clone (45±1) interacted strongly with the WT 4R/IRb
bait but not with the Y497F 4R/IRb bait (Figure 1D). InitialWe used the yeast two-hybrid system to identify pro-
teins that interact with the phosphorylated I4R motif sequence analysis suggested the 45±1 clone repre-
sented a previously uncharacterized gene. Since theof the IL-4R. A composite bait was constructed that
contained the I4R motif of the IL-4R fused to the kinase protein encoded by this gene interacted with the IL-
4R I4R motif, we designated it the IL-Four Receptordomain of the insulin receptor b (IRb); a comparable
bait containing the I4R motif of the insulin receptor has Interacting Protein, or FRIP. The genetic locus encoding
FRIP has been designated frip.been previously demonstrated to autophosphorylate
and interact with IRS-1 when expressed in yeast (O'Neill Northern analysis of RNA isolated from different tis-
sues showed that the 1.8 kb FRIP message was ex-et al., 1994). The composite bait (WT 4R/IRb) and a
control bait in which the central Y of the I4R motif had pressed only in lymphoid tissues, specifically thymus,
lymph node, and spleen (Figure 2A, lanes 1±7). Whenbeen mutated to F (Y497F 4R/IRb) were expressed as
LexA fusion proteins in yeast (Figure 1B). When the 4R/ RNA from isolated cells or cell lines were analyzed, ex-
pression was highest in normal T cells and T cell linesIRb bait was coexpressed with an IRS-1/transcription
activation domain fusion protein, activation of a LacZ (Figure 2A, lanes 8±11). Activation of normal CD41 T
cells with PMA, PMA1IL-4, or T cell receptor costimula-reporter gene was observed, indicating strong interac-
tion between IRS-1 and WT 4R/IRb (Figure 1C). The tion with anti-CD28 or IL-4 for 24 hr failed to alter frip
gene expression (K. N., unpublished data). FRIP mRNAY497F 4R/IRb bait failed to interact with IRS-1 as indi-
cated by loss of LacZ reporter expression (Figure 1C). expression was also high in the myeloid progenitor cell
lines FDC-P2 and 32D (lanes 14 and 15), while the mastThus, phosphorylation of the central Y of the I4R motif
is required for IRS-1 binding to the WT 4R/IRb bait. cell line CFTL-12 and several normal mast cell clones
(lanes 16±19) expressed low levels. FRIP message wasThese results also suggested that the 4R/IRb bait
could be used to screen cDNA libraries for additional not detected by Northern or RT-PCR analysis of RNA
isolated from normal splenic B cells and from the B cellmolecules that interact with the I4R motif of the IL-4R.
A mouse thymus cDNA library was screened with the lymphoma M12.4.1 (Figure 2A; unpublished data).
A full-length frip clone, isolated from a mouse thymus4R/IRb bait. From 500,000 independent yeast trans-
formants, 22 cDNAs encoding proteins that interacted cDNA library, contained a 1722 base pair (bp) insert with
an open reading frame encoding a protein of 412 aminospecifically with 4R/IRb were isolated. A counter screen
was performed using the Y497F 4R/IRb bait to eliminate acids and a predicted molecular weight of 46 kDa. Data-
base analysis using the full-length FRIP amino acid se-clones that did not require phosphorylation of the Y in
the I4R motif to interact. Two cDNAs were identified that quence indicated that there was a striking homology
between FRIP and the recently cloned rasGAP-associ-encoded proteins that required the presence of the Y
in the I4R motif of the IL-4R for interaction (Figure 1D). ated protein p62dok, with 38% identity and 53% similarity
in amino acid sequence overall (Figure 2B). SignificantOne of these was the adapter molecule SHC, which has
been shown to function as a molecular link between structural motifs were conserved between the two pro-
teins, including an N-terminal pleckstrin homology (PH)phosphorylated receptors and the Grb2/SOS complex,
thus catalyzing the activation of ras (Pelicci et al., 1992; domain, detected in theFRIP sequence using the Prosite
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domain of p62dok (Figure 2C) (Carpino et al., 1997; Yama-
nashi and Baltimore, 1997). This region of the IRS-1 PTB
domain includes two R residues that have been shown
to directly interact with the phosphorylated Y of the I4R
motif (Eck et al., 1996; Zhou et al., 1996); these R resi-
dues are conserved in FRIP and p62dok. Preliminary dele-
tion analyses of the FRIP protein have indicated that
this region is required for interaction with the phosphory-
lated I4R motif (K. N., unpublished data).
The C-terminal regions of FRIP and p62dok are more
diverse. This region of p62dok has previously been shown
to contain a number of potential Y phosphorylation and
SH2 domain-interaction sites, leading to the suggestion
that p62dok may act as a molecular adapter (Carpino et
al., 1997; Yamanashi and Baltimore, 1997). The C-ter-
minal domain of FRIP also contains a number of Y resi-
dues that may be sites of phosphorylation and/or in-
teraction with other proteins (Figure 2C). The relative
positions of Y residues outside of the PH and PTB do-
mains are not highly conserved between FRIP and
p62dok; however, several Y residues of the two molecules
have similar flanking sequences. In particular, Y residues
at positions 194, 276, 304, and 351 of FRIP are within
YxxP motifs that have been shown to interact with the
SH2 domains of Abl, Crk, and rasGAP (Songyang et al.,
1993). This motif is found six times in p62dok (Figure 2C).
The sequences surrounding other C-terminal Y resi-
dues are not conserved between FRIP and p62dok. The
C-terminal domains of both FRIP and p62dok are rich
in Pro residues (17.4% for FRIP and 21.4% for p62dok)
when compared to the N-terminal PH and PTB domains
(4.1% for FRIP and 4.4% for p62dok). Prorich sequences
have been shown to interact with SH3 domain signal-
ing molecules (Ren et al., 1993; Yu et al., 1994). Thus,
the C-terminal domains of FRIP and p62dok could be
potential targets for SH3 molecular interactions. The
high Pro content also might be important in attainingFigure 2. Northern and Sequence Analysis of the I4R Motif±
Interacting Protein FRIP specific secondary and tertiary structures in the C-termi-
(A) Northern blot analysis of frip gene expression in tissues and nal domains of FRIP and p62dok.
cell lines (upper) compared to total RNA determined by ethidium To determine whether FRIP was phosphorylated in
bromide staining of this gel (lower). response to IL-4 stimulation of hematopoietic cells, FRIP
(B) Amino acid sequence homology between FRIP and p62dok. PH
was expressed as an influenza hemagglutinin-taggedand PTB domain homologous regions are indicated.
molecule (HA-FRIP) in 32D myeloid progenitor cells(C) Primary amino acid sequence of the FRIPprotein. The PH domain
(32D/HA-FRIP). IL-4 stimulation induced Y phosphoryla-is boxed. The region homologous to the IRS-1 PTB domain is under-
lined. Conserved R residues interacting with PY are indicated (*). tion of the51 kDa HA-FRIP molecule, as shown by immu-
Potential SH2-binding sites (Songyang et al., 1993) are circled; po- noprecipitation of the protein with either anti-HA or anti-
tential Y phosphorylation sites (Songyang et al., 1995) are indicated phosphotyrosine (anti-PY) from transfected 32D cells
by arrows. (Figure 3A, lanes 5±8). The amount of HA-FRIP immuno-
precipitated by anti-PY was significantly lower than the
profile search, and a PTB domain. PH and PTB domains amount precipitated with anti-HA, suggesting that only
share similar secondary and tertiary structures and are a fraction of total HA-FRIP is phosphorylated in re-
found ina numberof signaling molecules (Pawson,1995; sponse to cytokine stimulation (Figure 3A lower, com-
Eck et al., 1996; Zhou et al., 1996). The PH domain has pare lanes 5±8 and 9±12). Induction of Y phosphorylation
been suggested to localize signaling molecules to the in untransfected 32D cells was not detected in the short
plasma membrane by interacting with phosphatidylino- exposure used for extracts from HA-FRIP transfected
sitol in the lipid bilayer (Yagisawa et al., 1994; Lemmon et cells, but similar patterns of phosphorylation were de-
al., 1995). The PTB domain has been shown to recognize tected after longer exposure of blots from untransfected
phosphorylated N-x-x-Y motifs such as that in the I4R cells (K. N., unpublished data).
motif (Trub et al., 1995; Wolf et al., 1995). Although the IL-3 also induced the Y phosphorylation of HA-FRIP
primary sequences of PTB domains can be quite diver- (Figure 3A, lanes 9±12). This was unexpected since the
gent, the FRIP PTB domain contains a region of homol- IL-3 receptor does not contain an I4R motif. However,
ogy to the PTB domains of the IRS-1 and IRS-2 mole- the IL-3 receptor b chain does contain the PTB domain
recognition sequence N-G-P-Y and has been shown tocules, as has been previously reported for the PTB
Immunity
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Figure 3. FRIP Is Phosphorylated and Inter-
acts with the rasGAP N-Terminal SH2 Domain
in Response to Cytokine Stimulation
(A) Phosphorylation of 51 kDa HA-FRIP
(arrow) was assayed in 32D cells stimulated
with IL-4 or IL-3. Extracts were immunopre-
cipitated (IP) with anti-HA or anti-PY and im-
munoblotted with anti-PY or anti-HA.
(B) HA-FRIP (arrow) was precipitated with
GST-fusion proteins containing the N-termi-
nal (lanes 1, 2, and 9±16) but not the C-termi-
nal (lanes 5 and 6) SH2 domain of rasGAP
from stimulated 32D/HA-FRIP or 293/HA-
FRIP cells. IL-2 stimulations were performed
on 32D/HA-FRIP cells expressing IL-2 recep-
tor b chain. HA-FRIP was coprecipitated with
anti-rasGAP from insulin-stimulated 293/HA-
FRIP cell extracts (lanes 17±20).
(C) FRIP phosphorylationand interaction with
rasGAP N-terminal SH2 domain requires the
Y497 of the human IL-4Ra. Independent cell
lines expressing wild-type (WT) or mutated
(Y497F) human IL-4Ra were stimulated with
mouse IL-4 (mIL-4) or human IL-4 (hIL-4) as
described (Keegan et al., 1994). Endogenous
FRIP bound by the rasGAP N-terminal SH2
domain GST-protein (upper, lanes 1±16) was
determined by anti-PY and anti-FRIPWestern
blot analyses. Asterisk (*) indicates the mobil-
ity of p62. Activation of STAT6 (lower, lanes
17±28) was determined by electrophoretic
mobility shift assay (EMSA).
activate the phosphorylation of SHC (Cutler et al., 1993; (Figure 3B, lanes 1±8). GST-fusion proteins containing
the SH3 domain of rasGAP or a non-rasGAP SH2 domainMatsuguchi et al., 1994). The weak background bands
observed in unstimulated 32D/HA-FRIP cells are likely (termed 117-1) also did not interact with HA-FRIP (K. N.,
unpublished data). Immunoblotting with anti-PY indi-due to residual phosphorylated HA-FRIP that accumu-
lated during growth of the 32D cells in IL-3 supple- cated that the HA-FRIP protein brought down by the
rasGAP N-terminal SH2 domain GST-fusion protein wasmented media (Figure 3A, lanes 5, 7, 9, and 11). IL-2
and insulin were also able to induce HA-FRIP Y phos- highly phosphorylated in cells stimulated with either
IL-3, IL-2, and IL-4 (Figure 3B, lanes 9±14). Phosphory-phorylation (K. N., data not shown). As with the IL-3
receptor, the b chains of the IL-2 and insulin receptors lated HA-FRIP from insulin-stimulated 293 fibroblast
cells expressing the HA-tagged FRIP (293/HA-FRIP) wascontain canonical PTB-domain recognition sequences.
p62dok was isolated based on its ability to interact also bound by the rasGAP N-terminal SH2 domain, indi-
cating that insulin can induce the phosphorylation ofwith rasGAP (Carpino et al., 1997; Yamanashi and Balti-
more, 1997). The high degree of homology between FRIP FRIP (Figure 3B, lane 16). Moreover, immunoprecipita-
tion of rasGAP from insulin-stimulated 293/HA-FRIPand p62dok suggested that FRIP might also be a rasGAP
interacting protein. The N-terminal SH2 domain of ras- cells resulted in the coprecipitation of phosphorylated
HA-FRIP (Figure 3B, lane 20) indicating that FRIP inter-GAP has been shown to mediate the interaction with
p62dok (Marengere and Pawson, 1992; Yamanashi and acts with endogenous rasGAP. Together, these results
strongly suggest that the N-terminal SH2 of rasGAP in-Baltimore, 1997). Thus, we tested the ability of the
N-terminal SH2 domain of rasGAP to bind HA-FRIP from teracts specifically with phosphorylated HA-FRIP after
insulin, IL-2, IL-3, or IL-4 stimulation.cells stimulated with various cytokines. A GST-fusion
protein containing the rasGAP N-terminal SH2 domain FRIP binds directly to the phosphorylated I4R motif
of the IL-4R in the yeast two-hybrid system. Thus, it isefficiently precipitated HA-FRIP from IL-3-stimulated
32D/HA-FRIP cells, while a similar GST-fusion con- likely that FRIP is phosphorylated by activated kinases
in the IL-4R complex once it has interacted with thetaining the C-terminal SH2 domain did not bind HA-FRIP
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IL-4R. A similar mechanism has been proposed for the by the anti-FRIP antisera. Thus, the amount of phos-
IL-4-stimulated phosphorylation of IRS-1 (Keegan et al., phorylated FRIP associated with the rasGAP N-terminal
1994). This predicts that the central Y of the I4R motif SH2 domain may be underestimated with this reagent.
would be critical for activation of FRIP phosphorylation The chromosomal location of frip was determined uti-
by IL-4. This was tested by examining the ability of I4R lizing the (C57BL6/JEi x SPRET/Ei)F1 female x SPRET/Ei
motif mutants of the human IL-4R (hIL-4R) to stimulate male (BSS) backcross panel of The Jackson Laboratory.
FRIP phosphorylation. Stably transfected 32D cell lines Using a polymorphism in the 39 region of the SPRET/Ei
expressing the wild-type (WT) or the Y497F I4R motif frip gene that resulted in the loss of an AluI site, the
mutant human IL-4R were stimulated with mouse or BSS backcross panel was typed, and the segregation
human IL-4. Phosphorylation of endogenously expressed pattern was compared to all other loci previously scored
FRIP was examined by precipitation with the rasGAP in this cross. The data for relevant markers are summa-
N-terminal SH2 domain GST-fusion protein and detec- rized in Figure 4A. The frip gene was localized to mouse
tion with anti-PY (Figure 3C). Two major Y phosphorylated chromosome 14 at a previously characterized locus
proteins were precipitated with the rasGAP N-terminal termed hairless (hr) (Figure 4A). Mice homozygous for
SH2 domain when two independent lines expressing the hairless allele (hr/hr) were shown to be highly sus-
similar levels of WT hIL-4R were stimulated with mouse ceptible to lymphocytic leukemia and found to exhibit
or human IL-4 (Figure 3C, lanes 1±6). The lower band lymphadenopathy and splenomegaly (Meier et al., 1963;
migrated at 49 kDa, the expected molecular weight of Heiniger et al., 1974). Defects in the in vitro response of
FRIP, while the upper band (*) migrated at 62 kDa and hr/hr T cells also have been reported (Reske-Kunz et al.,
is likely to be p62dok. An unidentified, higher molecular 1979; Morrissey et al., 1980). Recently, an endogenous
weight band was seen in some extracts. Antisera raised retrovirus was shown to segregate with the hr allele,
to a FRIP peptide were used to blot these precipitates, and a revertant mouse was identified that had lost both
and only the lower band was detected, indicating the this provirus and the hairless phenotype, suggesting
49 kDa phosphoprotein observed in stimulated extracts that this phenotype resulted from the disruption of a
was endogenous FRIP (Figure 3C, lane 13±16). gene by the viral integration (Stoye et al., 1988). A puta-
In contrast, two independent cell lines expressing tive zinc-finger gene termed hairless, expressed only in
equivalent levels of the Y497F mutant hIL-4R failed to skin and brain tissue, was cloned using the identified
induce the phosphorylation of either FRIP or p62 in re-
provirus as a genetic probe (Canchon-Gonzalez, 1994).
sponse to hIL-4 stimulation (Figure 3C, lanes 7±12). The
No expression of the hairless gene in lymphoid tissue
loss of function of the Y497F hIL-4R was restricted to
was detected. Thus, it seemed likely that the leukemia/
pathways requiring the I4R motif, since activation of
immunological phenotype of hr/hr mice might reflect
Stat6 by mouse and human IL-4, which requires Y resi-
additional genetic abnormalities.
dues C-terminal to the I4R motif (Ryan et al., 1996), was
Because the hr abnormality locus and frip are linked,equivalent in thesecells (Figure 3C, lower). These results
we asked whether alterations in frip gene expressionstrongly suggest that the central Y of the I4R motif is
might contribute to the previously described immuno-required for stimulating the phosphorylation of FRIP and
logical disorders associated with the hr allele. Northernp62dok. Together with the observation that FRIP can in-
analyses were performed on total RNA isolated fromteract directly with the phosphorylated I4R motif in the
lymph node T cells of hr/hr and 1/hr control mice. hr/yeast two-hybrid system, these data strongly suggest
hr mice had significantly lower levels of FRIP mRNAthat FRIP binds to the I4R motif of the IL-4R and that
than 1/hr mice (Figure 4B). When normalized to thethis interaction requires phosphorylation of the central
amount of b-actin in each sample, the levels of FRIPY residueof the I4R motif. Taken together with the obser-
message were 3- to 5-fold lower in hr/hr mice than invation that FRIP interacts with the N-terminal SH2 do-
1/hr mice. The reduced level of FRIP mRNA expressedmain of rasGAP, it is likely that FRIP acts as an adapter
in hr/hr mice did not appear to change as mice agedmolecule between phosphorylated N-x-x-Y receptor
over several months (Figure 4D).motifs and rasGAP.
FRIP protein levels were also significantly reduced inSomewhat surprisingly, the level of endogenous FRIP
hr/hr mice as indicated by the Western blot analysis ofthat associates with the N-terminal SH2 domain of ras-
total spleen extracts prepared from 1/1 and hr/hr miceGAP increases approximately 2-fold upon stimulation,
using antisera toFRIP (Figure 4C). Reprobing these blotswhile the level of phosphorylation increases more than
with antisera to p56lck indicated that similar levels of5-fold (Figure 3C, lanes 13 and 14). This differs from
protein were assayed from the 1/1 and hr/hr spleenthe results obtained with transfected HA-FRIP, which
extracts. Expression of dok mRNA was not reduced inshowed a 5-fold increase in rasGAP N-terminal SH2
hr/hr mice and was expressed at high levels in the lymphdomain association upon stimulation (Figures 3A and
node T cells of both hr/hr and 1/1 mice (Figure 4D). The3B). These results suggest that there may be a certain
reduced expression of FRIP appears to be specificallydegree of FRIP-rasGAP interaction in unstimulated cells
associated with the hr allele, and the altered expressionthat increases only modestly upon cytokine stimulation.
of FRIP is a strong candidate for the cause of the geneticOverexpression of the HA-FRIP protein may enable a
defect leading to the hematologic/immunologic pheno-higher level of HA-FRIP and rasGAP interaction to be
type of hr/hr mice.detected after cytokine stimulation. However, since the
As in previous reports, we observed striking lymph-peptide used to generate the anti-FRIP antisera contains
adenopathy in mice 8±12 weeks of age (Figure 5A) (Meiera potential site of Y phosphorylation (Y276), it is also
et al., 1963). Splenomegaly was also observed but waspossible that phosphorylated FRIP associated with ras-
GAP N-terminal SH2 domain is not recognized efficiently not as marked as the lymphadenopathy. Axillary lymph
Immunity
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Figure 4. Genetic Mapping of the frip Gene
and Analysis of FRIP Expression in hairless
Mice
(A) Haplotype figure from Jackson BSS back-
cross showing Chromosome 14 loci linked to
frip (top most proximal). C57BL6/JEi alleles
(black boxes) and SPRET/Ei alleles (white
boxes) are indicated with number of animals
with each haplotype at bottom. Percent re-
combination (R) between adjacent loci is
given at right with the standard error (SE) for
each R. Missing typings were inferred from
surrounding data where assignment was un-
ambiguous. Raw data from The Jackson Lab-
oratory can be obtained on the World Wide
Web.
(B) Northern analysis of frip gene expression
in axillary lymph node T cells from hr/hr and
heterozygous control mice. Band intensities
of RNA (8, 6, 4, 3, 2, or 1 mg per lane) were
determined by densitometry and normalized
to b-actin expression (FRIP/b-ACTIN). Ratio
of normalized values from each dilution is
given [CONTROL/(hr/hr)].
(C) Western blot analysis of FRIP protein expression in protein extracts isolated from total spleens of hr/hr or control (1/1) HRS/J mice (40,
20, 10, 5, 2.5, or 1.25 mg total spleen extract per lane). Blots were probed with antisera raised to the FRIP peptide and reprobed with anti-
p56lck.
(D) Northern analysis of FRIP and p62dok RNA expression in axillary lymph node T cells from 4- and 12-week-old hr/hr and heterozygous
control mice (4, 3, 2, or 1 mg total RNA per lane).
node enlargement was observed in 8-week-old animals found to be similar when stimulated with anti-IgM and
IL-4 (K. N., unpublished data). This is consistent withand occurred prior to mesenteric node enlargement,
which was first observed in 12-week-old animals (K. N., the idea that FRIP, which is not expressed in B cells, is
critical in regulating the proliferative response of T cells.unpublished data). Noticeable lymphadenopathy was
not observed in 4-week-old hr/hr mice, although frip Thus, the reduced expression of FRIP may contribute
to the hyperproliferation of hr/hr T cells, and FRIP maygene expression was reduced in these animals (Figure
4C). Flow cytometric analysis of T cells from enlarged function as a negative regulator of T cell proliferation.
Because FRIP interacts directly with rasGAP, a negativeperipheral lymph nodes of hr/hr mice revealed no de-
tectable difference from those of 1/hr cells in the ex- regulator of ras activation, we examined the effect of
FRIP overexpression on activation of components of thepression of CD25, CD62L, CD44, or CD45RB (data not
shown). A normal distribution of CD4 and CD8 cells was ras activation pathway. Initially, we examined the effect
of FRIP expression on IL-2-induced AP-1 activation.also observed (K. N., unpublished data).
We analyzed the ability of T cells isolated from the AP-1 is a complex of Fos and Jun proteins that are
induced and activated in response to the activation ofenlarged axillary lymph nodes of hr/hr mice to incorpo-
rate 3H-thymidine as an indicator of their response to T small GTPases such as ras (Angel and Karin, 1991). IL-2
in particular has been shown to activate ras and MAPKcell receptor and cytokine-mediated stimulation. Un-
stimulated lymph node T cells from both hr/hr and 1/hr pathways leading to Fos and Jun activation (Shibuya et
al., 1992; Perkins et al., 1993). Transient expression ofmice had equally low background levels of 3H-thymi-
dine incorporation. Stimulation with anti-CD3 alone in- FRIP inA.E7 cellsdramatically reduced the AP-1-depen-
dent expression of a luciferase reporter gene inducedcreased the 3H-thymidine uptake of hr/hr T cells to a
greater extent than 1/hr T cells (Figure 5B). More strik- by IL-2 (Figure 6A). Additionally, when we examined the
direct effect of FRIP overexpression on MAPK activationingly, the addition of IL-2 caused a significant increase
in the incorporation of 3H-thymidine by hr/hr cells com- in 32D cells cotransfected with the IL-2Rb and FRIP,
there was a consistent diminution in the activation ofpared to that of 1/hr cells (Figure 5B). Addition of IL-4
also substantially increased 3H-thymidine uptake by hr/ MAPK in response to IL-2 over 30 min of stimulation
(Figure 6B). Together, these data suggest that FRIPhr cells over that seen in 1/hr cells. This difference
was preserved when endogenously produced IL-2 was overexpression can diminish the induction of pathways
that require the activation of ras.neutralized by anti-mouse IL-2 antibody. A similar but
greater increase in 3H-thymidine uptake by hr/hr cells
over 1/hr cells was observed when both IL-2 and IL-4
were added. Thus, both IL-2 and IL-4 elicited greater Discussion
responses in hr/hr T cells than in 1/hr T cells. The uptake
of 3H-thymidine in response to IL-2 and IL-4 hr/hr T cells The cytoplasmic domain of the IL-4R has been shown
to be comprised of functionally distinct domains in-varied from 5- to 10-fold higher than that of 1/hr T cells
in multiple experiments. In contrast, the proliferation of volved in the activation of IL-4 responsive genes and in
the stimulation of a proliferative response to IL-4. Thesplenic B cells derived from hr/hr or control mice was
FRIP, a rasGAP-Associated Protein of Hematopoietic Cells
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Figure 5. Lymphadenopathy and T Cell Hy-
perproliferation of hairless Mice
(A) Lymphadenopathy of axillary lymphnodes
(arrow) in hr/hr mice.
(B) Proliferation of axillary lymph node T cells
from hr/hr and 1/hr mice. T cells (5.5 3 104
cells/ml) were isolated and stimulated with 1
mg/mL anti-CD3 in the presence of irradiated
APC 6 1 U/ml IL-2, 100 U/ml IL-4, 10 mg/ml
S4B6 (aIL-2), or 10 mg/ml 11B11 (aIL-4) for
48 hr and pulsed with 3H-thymidine.
domain critical for stimulating the growth of hematopoi- FRIP, the second I4R-interacting molecule identified,
is a new member of a family of PTB domain adapteretic cells lines contains a sequence, the I4R motif,
shared by other receptors that utilize the IRS-1/IRS-2 molecules that interact with the rasGAP N-terminal SH2
domain. The other identified member of this family,signaling pathway. We now have identified two addi-
tional signaling molecules that interact with the I4R motif p62dok, was identified as the major rasGAP-associated
phosphorylated protein in human chronic myelogenousand play potentially critical roles in IL-4R signaling.
One of these molecules, SHC, has been studied exten- leukemia cells and v-abl transformed preB cells (Carpino
et al., 1997; Yamanashi and Baltimore, 1997). It shouldsively and shown to be a critical adapter linking acti-
vated receptors to the ras pathway (Pelicci et al., 1992; be noted that, after submission of this manuscript, a
paper appeared (Di Cristofano et al., 1998) describingRozakis-Adcock et al., 1992; Salcini et al., 1994). Previ-
ous reports had suggested that IL-4 fails to activate the purification and cloning of a molecule identical to
FRIP, designated p56dok-2. Comparison of the primarySHC phosphorylation (Welham et al., 1994). However,
IL-4 stimulation of B cells has recently been shown to amino acid sequence of FRIP and p62dok indicated these
proteins share the same overall structure and haveresult in SHC phosphorylation (Crowley et al., 1996).
We have observed modest SHC phosphorylation in re- highly conserved PH and PTB domains. It is likely the
PTB domains of FRIP and p62dok mediate the interactionsponse to IL-4 stimulation of the myeloid progenitor cell
line 32D and the T cell line CT.4R, neither of which with the I4R motif of the IL-4R since the central Y of this
motif is within the canonical PTB domain recognitionexpresses IRS-1 or IRS-2 (K. N., unpublished data). In-
deed, IL-4 has been shown to promote the survival of motif, N-x-x-Y, and the PTB-domains of FRIP and p62dok
are homologous to that of IRS-1/IRS-2. FRIP was shown32D cells and to stimulate a vigorous proliferative re-
sponse in CT.4R cells in the absence of IRS-1/IRS-2 to interact directly with the phosphorylated I4R motif in
the yeast two-hybrid system, and mutation of the centralexpression (Hu-Li et al., 1989; Zamorano et al., 1996).
Thus, activation of SHC may play a role in growth and Y of the I4R motif blocked the IL-4-stimulated phosphor-
ylation of FRIP as well as a 62 kDa molecule that isin the prevention of apoptosis of cells that do not ex-
press IRS-1/IRS-2. likely p62dok. In addition to IL-4, IL-2, IL-3, and insulin
Immunity
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Figure 6. FRIP Overexpression Diminishes AP-1 and MAPK Acti-
vation
(A) A.E7 cells were cotransfected transiently with a luciferase ex-
Figure 7. Models of FRIP Inhibition of ras Activationpression vector under the control of 6 AP-1-binding sites (pGL2-
TRE-6Luc) plus control (A.E7/CONT) or HA-FRIP expression vectors (A) Potential role of FRIP as a molecular link between rasGAP and
(A.E7/FRIP), cultured 24 hr in the presence or absence of 2000 U/mL phosphorylated cytokine receptors. Additional molecules (?) may
IL-2, and assayed for luciferase activity. These data are the average interact with phosphorylated FRIP. FRIP-rasGAP interactions are
of two independent transfections. analogous but act in opposition to the interactions between SHC
(B) 32D cells were cotransfected transiently with the human IL- or IRS-1/2 and the Grb2/SOS complex.
2Rb receptor plus 5-fold excess control (CONT) or HA-FRIP (FRIP) (B) FRIP could also function by blocking the interaction of PTB-
expression vectors. After 24 hr, cells were starved and then stimu- domain proteins such as IRS-1/2 and Shc with phosphorylated re-
lated with human IL-2 for 0, 10, or 30 min. Whole cell extracts were ceptors and thus inhibit ras activation.
analyzed by Western immunoblotting with antibodies specific for
activated MAPK (phospho-MAPK), total MAPK (MAPK), or HA-
FRIP (HA).
that phosphorylated forms of FRIP and p62dok interact
with signaling molecules in addition to rasGAP that may
mediate distinct functions. Thus, phosphorylation ofstimulated the phosphorylation of FRIP. The receptors
for these cytokines contain N-x-x-Y motifs and have unique C-terminal sequences in FRIP and p62dok may
allow a different array of molecular interactions to occur.been shown to be induce the phosphorylation of the
PTB domain protein SHC (Burns et al., 1993; Ravichand- Determining what molecules interact with the phosphor-
ylated FRIP and p62dok molecules in different tissuesran and Burakoff, 1994; Evans et al., 1995).
Although structurally related, sequence differences in may lead to a clearer delineation of the role these mole-
cules play in cytokine signaling.the FRIP and p62dok molecules may reflect divergent
functionalities. FRIP, unlike p62dok, appears to bespecifi- Genetic analysis indicates that the frip gene is linked
to the hr locus on mouse chromosome 14 and that bothcally expressed in cellsof thehematopoietic lineage with
the notable exception of B cells, which do not express FRIP mRNA and protein are underexpressed 3- to 5-fold
in hr/hr mice. The concomitant increase in the prolifera-detectable FRIP message. It is interesting to speculate
that the differential tissue distribution of FRIP and p62dok tion of hr/hr T cells in response to cytokine and TCR
stimulation has led us to propose the hypothesis thatreflects differences in the relative importance of these
molecules to signaling processes in these cells. In par- FRIP is a negative regulator of cytokine-induced T cell
proliferation. The observation that IL-2-induced AP-1ticular, the high level of FRIP expression in T cells may
reflect its importance in T cell signaling processes. and MAPK activation were diminished by transient over-
expression of FRIP further substantiates the potentialIn addition to differing in tissue expression, FRIP and
p62dok have distinct C-terminal domains containing a role of FRIP as a negative regulator of the ras activation
pathway (Figure 6). Together, these observations sug-number of Y phosphorylation and SH2 domain recogni-
tion motifs. Although the rasGAP SH2 domain recogni- gest that lowered FRIP expression in hr/hr T cells may
result in cellular hyperproliferation due to the impairedtion motif Y-x-x-P is found in the C-terminal domains of
both FRIP and p62dok, other Y residues are found in the negative regulation of ras.
Potential mechanisms by which FRIP could mediatecontext of distinct sequences (Figure 2C). It is possible
FRIP, a rasGAP-Associated Protein of Hematopoietic Cells
21
such negative regulation are presented in Figure 7. Bio- activation of these pathways is modulated. The adapter
molecules IRS-1/IRS-2 and SHC have been suggestedchemical and genetic evidence has indicated the impor-
tance of SHC and IRS-1/IRS-2 as molecular adapters to stimulate cellular proliferation by linking cytokine re-
ceptors to the ras pathway via the Grb2/SOS complex.that link activated receptors to the Grb2/SOS guanine
nucleotide exchange complex (Rozakis-Adcock et al., Here, we have shown that a new member of the PTB
domain family of adapter molecules, FRIP, may partici-1992; Myers et al., 1994; Salcini et al., 1994). This molec-
ular linkage results in the accumulation of the activated pate in the diminution of T cell proliferation by linking
cytokine receptors to the ras inactivating protein rasGAP.ras-GTP that activates raf kinase, which in turn initiates
the MAP kinase cascade. Activation of this cascade has
been shown to be critical for cellular proliferation (Alessi Experimental Procedures
et al., 1994; Margolis and Skolnik, 1994; Zheng and
Yeast Two-Hybrid System and cDNA CloningGuan, 1994). FRIP could act as an adapter that links
Yeast strains and expression vectors have been previously de-rasGAP to activated receptors (Figure 7A). It is not clear
scribed (Golemis and Brent, 1992). The insulin receptor b bait con-
if this linkage is a direct one creating a complex of taining the kinase domain (pLexA.IR.cyto) and the IRS-1 (pAcid.
activated receptors, FRIP, and rasGAP, or if FRIP inter- IRS-1.45-516) yeast expression vectors were provided by Thomas
acts with the phosphorylated receptor, becomes phos- Gustafson, Metabolex, San Francisco, CA (O'Neill et al., 1994). Hu-
man IL-4R/insulin receptor kinase composite baits containing wild-phorylated, diffuses away, and then interacts with ras-
type (4R/IRb) or Y497F mutant (Y497F 4R/IRb) forms of the humanGAP. In the latter case, the PH domain of FRIP might
IL-4R I4R motif were constructed by inserting double-stranded oli-localize rasGAP-FRIP complexes to the plasma mem-
gonucleotides into the EcoRI and internal XhoI site of the pLexA.IR.-
brane in the vicinity of the activated cytokine receptor. cyto plasmid, replacing 45 residues of the insulin receptor with the
In either situation, the local concentration of rasGAP IL-4Ra I4R motif coding sequence. A mouse thymus cDNA library
around activated receptors would be predicted to in- in theyeast expression vector JG4±5 (from the laboratory of Fredrick
Alt) was screened with the 4R/IRb bait according to described proto-crease after its interaction with FRIP. Since rasGAP
cols (Gyuris et al., 1993; Zervos et al., 1993). Isolated clones wereincreases the GTPase activity of ras and functionally
sequenced by Paragon Biotech, Inc. (Baltimore, MD), and full-lengthinactivates ras (Boguski and McCormick, 1993; Down-
clones were obtained by screening a mouse thymus cDNA (Stra-
ward, 1996), increasing the concentration of rasGAP tagene, La Jolla, CA).
near activated receptors could lead to the hydrolysis of
rasGTP that had accumulated as a result of activation Northern Blot Analysis
by adapter-Grb2/SOS complexes. It is also possible Total RNA was isolated using RNAzol (Tel-Test, Incorporated,
Friendswood, TX) according to the manufacturer's specifications.that, as well as acting as a link between receptors and
Northern blots were probed with the FRIP cDNA from the plasmidrasGAP, FRIP may interact with additional proteins that
45±1 identified in the yeast two-hybrid library screen. A mouse dokcontribute to the regulation of receptor signaling.
cDNA probe was amplified from the first 716 bp of coding sequence
In addition, FRIP may physically block the access of by RT-PCR using the primers 59ATGGACGGGGCTGTGATGGAGGG
other PTB-domain proteins such as IRS-1/2 and Shc to TCCG and 59GATTTCCCTGAGAAGTCTGGAAGGTGAAGGTCCC.
phosphorylated receptor motifs (Figure 7B). Although Northern blot band intensities were quantitated using a Molecular
Dynamics ImageQuant densitometer.this mechanism does not account for the interaction of
FRIP with rasGAP, itmay also contribute to the observed
Cell Culture and Transfectioneffects of FRIP overexpression on AP-1 and MAPK acti-
The IL-3-dependent myeloid progenitor cell line 32D was maintainedvation in transient transfected cells.
as described (Keegan et al., 1994). 293 fibroblasts were maintained
This model also predicts that p62dok could link rasGAP in supplemented DMEM with 10% FCS. Vectors containing human
to activated receptors. Although the function of p62dok IL-4R and IL-2Rb cDNAs have been described (Keegan et al., 1994;
has not been delineated, the high level of p62dok phos- Wang et al., 1996). HA-tagged FRIP cDNA was generated by ligating
a double-stranded oligonucleotide containing a Kozak sequencephorylation in Abl transformed cells has led to the hy-
and an HA tag (59 GGTACCGCCACCATGGCATACCCTTATGATGTGpothesis that p62dok phosphorylation contributes to the
CCAGATTATGCCTCTGAATTC) between the plasmid Asp718 site andtransformed state and may activate growth pathways
the 59 EcoRI site of the cDNA and subcloning into the pcDNA3.1(1)(Carpino et al., 1997; Yamanashi and Baltimore, 1997).
(Invitrogen) or pAlterMAX (Promega) expression vectors. The pGL2-
Thus, FRIP and p62dok may mediate opposite effects TRE-6 Luciferase reporter was obtained from Charles Zacharchuck
on rasGAP function and, ultimately, ras activation. It is (National Cancer Institute). 32D stable transfections were performed
as previously described (Keegan et al., 1994). Cells (293) werepossible that the divergent C-terminal domains of FRIP
transfected using the Fugene6 reagent (Boehringer Mannheim). 32Dand p62dok mediate interactions with proteins that pro-
transient transfections wereperformed as above butelectroporationmote rasGAP activation or inactivation, respectively. Al-
was done at 260V, 720 ohms, and 1050 mF. A.E7 cells wereternatively, Abl transformation of B cells may mask a
transfected by particle-mediated gene transfer, and luciferase
growth inhibitory effect of p62dok. assays were performed as described (Huang et al., 1997).
It is becoming increasingly evident that negative regu-
latory pathways are critical to the control of receptor Immunoprecipitation and Western Blot Analysis
signaling. In particular, the effects of activating receptor- Immunoprecipitation analyses were performed using methods pre-
viously described (Keegan et al., 1994). 32D cells (107) were washedassociated tyrosine kinases have been shown to be
and resuspended in RPMI without serum for 4 hr at 378C and thencountered by the activation of tyrosine phosphatases,
incubated in the presence or absence of mouse IL-4 (2 ng/mL),such as SHP-1/SHP-2, or by the direct interaction with
human IL-4 (20 ng/mL), human IL-2 (100 U/mL), mouse IL-3 (1000
other molecules, such as Cbl (Scharenberg and Kinet, U/mL), or human insulin (400 mg/ML) for 15 min at 378C. Lysates
1996; Ota and Samelson, 1997). Although the pathways were immunoprecipitated with 15 mg monoclonal antibody to phos-
leading to the activation of the ras/MAP kinase signaling photyrosine (4G10) (Upstate Biotechnology, Inc.) oranti-hemaggluti-
nin epitope tag (12CA5) (Boehringer Mannheim) bound to protein-Gcascade are well documented, it is not clear how the
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sepharose (Pharmacia). Agarose-conjugated GST-fusion proteins Burns, L.A., Karnitz, L.M., Sutor, S.L., and Abraham, R.T. (1993).
Interleukin-2-induced tyrosine phosphorylation of p52shc in T lym-containing the rasGAP N-terminal or C-terminal SH2 domain (Up-
phocytes. J. Biol. Chem. 268, 17659±17661.state Biotechnology, Inc.) were used to directly precipitate cytosolic
proteins. Western blot analysis was performed as described (Kee- Canchon-Gonzalez, M.B. (1994). Structure and expression of the
gan et al., 1994), and blots were probed with 1 mg/ml 4G10 or 12CA5 hairless gene of mice. Proc. Natl. Acad. Sci. USA 91, 7717±7721.
monoclonal antibody and detected with 1:10,000 diluted anti-mouse Carpino, N., Wisniewski, D., Strife, A., Marshak, D., Kobayashi, R.,
k chain antisera coupled to horse radish peroxidase (Southern Stillman, B., and Clarkson, B. (1997). p62(dok): a constitutively tyro-
Biotechnology Associates, Inc.) and chemiluminescent substrates sine-phosphorylated, GAP-associated protein in chronic myeloge-
(Pierce). Anti-FRIP antisera were generated by immunizing rabbits nous leukemia progenitor cells. Cell 88, 197±204.
with thepeptide 45PEP.3(CRPESPYSRPHDSLP) coupled to keyhole
Coffman, R.L., Lebman, D.A., and Rothman, P. (1993). Mechanismlimpet hemocyanin. Monoclonal antibody to the p56lck (Santa Cruz
and regulation of immunoglobulin isotype switching. Adv. Immunol.Biotechnology) protein was used according to the manufacturer's
54, 229±270.specifications. Total cell extractswere analyzed for MAPK activation
Conrad, D., Waldschmidt, T.J., Lee, W.T., Rao, M., Keegan, A.D.,with gels loaded equivalently according to protein content and blot-
Noelle, R.J., Lynch, R.G., and Kehry, M.R. (1987). Effect of B cellted using antibodies to activated MAPK (Santa Cruz Biotechnology)
stimulatory factor-1 (interleukin-4) on Fc epsilon and Fc gammaor total MAPK (New England Biolabs).
receptor expression on murine B lymphocytes and B cell lines. J.
Immunol. 139, 2290±2296.Electrophoretic Mobility Shift Assay
Crowley, M.T., Harmer, S.L., and DeFranco, A.L. (1996). Activation-Nuclear extracts from 32D cells were prepared and analyzed as
induced association of a 145-kDa tyrosine-phosphorylated proteindescribed previously (Ryan et al., 1996). The DNA probe 4GL3, used
with Shc and Syk in B lymphocytes and macrophages. J. Biol. Chem.to specifically detect STAT6 binding activity, was derived from se-
271, 1145±1152.quences in the mIL-4 promoter region and is described in detail
Cutler, R.L., Liu, L., Damen, J.E., and Krystal, G. (1993). Multipleelsewhere (Huang et al., 1997).
cytokines induce the tyrosine phosphorylation of Shc and its associ-
ation with Grb2 in hemopoietic cells. J. Biol. Chem. 268, 21463±Genetic Mapping
21465.Mapping of the frip gene was done with assistance from The Jack-
Di Cristofano, A., Carpino, N., Dunant, N., Friedland, G., Kobayashi,son Laboratories backcross mapping service using the [(C57BL6/
R., Strife, A., Wisniewski, D., Clarkson, B., Paolo Pandolfi, P., andJEi x SPRET/Ei)F1 x SPRET/Ei] (BSS) backcross panel. A 600 bp
Resh, M.D. (1998). Molecular cloning and characterization of p56dok-2PCR fragment was amplified from the 39 end of the frip gene using
defines a new family of RasGAP-binding proteins. J. Biol. Chem.the primers 59 GCCGTACCCTTTGATACGGTGGCTCACTCCCTGAG
273, 4827±4830.(forward) and 59 TGGAAACCCTTTGTCTCTTAAGAGAAATGGCCC
CAG (reverse). The C57BL6/JEi allele contained an additional AluI Downward, J. (1996). Control of ras activation. Cancer Surv. 27,
site at position 442 of the PCR fragment that gave a diagnostic 158 87±100.
bp fragment in AluI digests. PCR fragments generated from the 94 Eck, M.J., Dhe-Paganon, S., Trub, T., Nolte, R.T., and Shoelson, S.E.
animals in the BSS backcross were digested with AluI and analyzed (1996). Structure of the IRS-1 PTB domain bound to the juxtamem-
by gel electrophoresis on 2% agarose gels. brane region of the insulin receptor. Cell 85, 695±705.
Evans, G.A., Goldsmith, M.A., Johnston, J.A., Xu, W., Weiler, S.R.,
Proliferation Assays Erwin, R., Howard, O.M., Abraham, R.T., O'Shea, J.J., Greene, W.C.,
hr/hr and 1/hr HRS/J mice were obtained from The Jackson Labora- et al. (1995). Analysis of interleukin-2-dependent signal transduction
tory (BarHarbor, ME). Lymph nodeT cells were isolated as described through the Shc/Grb2 adapter pathway. Interleukin-2-dependent
(Hu-Li et al., 1997). Proliferation of hr/hr or 1/hr LN T cells was mitogenesis does not requireShc phosphorylation or receptor asso-
assayed as described (Hu-Li et al., 1997) using LN T cells (at 5 3 ciation. J. Biol. Chem. 270, 28858±28863.
104, 1.5 3 105, or 5 3 105 cells per ml) with irradiated APC (105 cells/
Golemis, E.A., and Brent, R. (1992). Fused protein domains inhibitml) and 1 mg/mL anti-CD3 antibody (2C11) in 0.2 ml complete RPMI
DNA binding by LexA. Mol. Cell Biol. 12, 3006±3014.
containing various cytokines or blocking antibodies as indicated
Gyuris, J., Golemis, E., Chertkov, H., and Brent, R. (1993). Cdi1, a(Figure 5B). HRS/J breeding pairs were obtained from The Jackson
human G1 and S phase protein phosphatase that associates withLaboratory and bred to obtain 1/1 HRS/J mice.
Cdk2. Cell 75, 791±803.
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